Manufacturer record

Laborate Pharmaceuticals India Ltd (Unit-ii) 31: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

3 batches manufactured by Laborate Pharmaceuticals India Ltd (Unit-ii) 31 (Himachal Pradesh) were declared Not of Standard Quality between February 2025 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: PTKLA004, Montelukast & Levocetirizine Hydrochloride Syrup (exp Oct 2027). SFDTL, Uttarakhand (state lab) found it not of standard quality: Assay of Levocetirizine Hydrochloride. Listed in the August 2026 alert.

Records by type

3 records linked to Laborate Pharmaceuticals India Ltd (Unit-ii) 31 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
3Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Feb 2025 to Aug 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

3
NSQ batches since 2025
3
Products affected
Assay
Most common failure
Aug 2026
Latest alert

Flagged batches per year

2025 · 22026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Montelukast & Levocetirizine Hydrochloride Syrup Batch PTKLA004Mfg Nov 2025 · Exp Oct 2027 Assay of Levocetirizine HydrochlorideAssay SFDTL, UttarakhandState lab Aug 2026
Rabeprazole & Domperidone Capsules Batch ORECA-004Mfg Apr 2024 · Exp Mar 2026 Rabeprazole & Domperidone Capsules does not comply Rabeprazole sodium Assay as per STPAssay DCL TelanganaState lab Nov 2025
Para 500 Batch NBRT- 018Mfg May 2023 · Exp Apr 2026 The sample does not conforms to the IP 2022 requirement w.r.t dissolution testDissolution DTL Srinagar (J&K)State lab Feb 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.